Global Adult Vaccine Market Research Report 2020


This report focuses on Adult Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adult Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GlaxoSmithKline
    Sanofi Pasteur
    Merck
    Novartis
    Pfizer
    BioCSL (Seqirus)
    Protein Sciences
    ...

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Influenza
    Cervical Cancer
    Zoster Shingles
    Pneumococcal
    Meningococcal
    MMRV
    Hepatitis
    DTP
    Travel and Miscellaneous

Segment by Application
    Hospitals
    Medical Care Centers
    Other
Table of Contents

1 Adult Vaccine Market Overview
    1.1 Product Overview and Scope of Adult Vaccine
    1.2 Adult Vaccine Segment by Type
        1.2.1 Global Adult Vaccine Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 Influenza
        1.2.3 Cervical Cancer
        1.2.4 Zoster Shingles
        1.2.5 Pneumococcal
        1.2.6 Meningococcal
        1.2.7 MMRV
        1.2.8 Hepatitis
        1.2.9 DTP
        1.2.10 Travel and Miscellaneous
    1.3 Adult Vaccine Segment by Application
        1.3.1 Adult Vaccine Sales Comparison by Application: 2020 VS 2026
        1.3.2 Hospitals
        1.3.3 Medical Care Centers
        1.3.4 Other
    1.4 Global Adult Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Adult Vaccine Revenue 2015-2026
        1.4.2 Global Adult Vaccine Sales 2015-2026
        1.4.3 Adult Vaccine Market Size by Region: 2020 Versus 2026

2 Global Adult Vaccine Market Competition by Manufacturers
    2.1 Global Adult Vaccine Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Adult Vaccine Revenue Share by Manufacturers (2015-2020)
    2.3 Global Adult Vaccine Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Adult Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Adult Vaccine Market Competitive Situation and Trends
        2.5.1 Adult Vaccine Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Adult Vaccine Players (Opinion Leaders)

3 Adult Vaccine Retrospective Market Scenario by Region
    3.1 Global Adult Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Adult Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Adult Vaccine Market Facts & Figures by Country
        3.3.1 North America Adult Vaccine Sales by Country
        3.3.2 North America Adult Vaccine Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Adult Vaccine Market Facts & Figures by Country
        3.4.1 Europe Adult Vaccine Sales by Country
        3.4.2 Europe Adult Vaccine Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Adult Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Adult Vaccine Sales by Region
        3.5.2 Asia Pacific Adult Vaccine Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Adult Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Adult Vaccine Sales by Country
        3.6.2 Latin America Adult Vaccine Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Adult Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Adult Vaccine Sales by Country
        3.7.2 Middle East and Africa Adult Vaccine Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Adult Vaccine Historic Market Analysis by Type
    4.1 Global Adult Vaccine Sales Market Share by Type (2015-2020)
    4.2 Global Adult Vaccine Revenue Market Share by Type (2015-2020)
    4.3 Global Adult Vaccine Price Market Share by Type (2015-2020)
    4.4 Global Adult Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Adult Vaccine Historic Market Analysis by Application
    5.1 Global Adult Vaccine Sales Market Share by Application (2015-2020)
    5.2 Global Adult Vaccine Revenue Market Share by Application (2015-2020)
    5.3 Global Adult Vaccine Price by Application (2015-2020)

6 Company Profiles and Key Figures in Adult Vaccine Business
    6.1 GlaxoSmithKline
        6.1.1 Corporation Information
        6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
        6.1.3 GlaxoSmithKline Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 GlaxoSmithKline Products Offered
        6.1.5 GlaxoSmithKline Recent Development
    6.2 Sanofi Pasteur
        6.2.1 Sanofi Pasteur Adult Vaccine Production Sites and Area Served
        6.2.2 Sanofi Pasteur Description, Business Overview and Total Revenue
        6.2.3 Sanofi Pasteur Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Sanofi Pasteur Products Offered
        6.2.5 Sanofi Pasteur Recent Development
    6.3 Merck
        6.3.1 Merck Adult Vaccine Production Sites and Area Served
        6.3.2 Merck Description, Business Overview and Total Revenue
        6.3.3 Merck Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Merck Products Offered
        6.3.5 Merck Recent Development
    6.4 Novartis
        6.4.1 Novartis Adult Vaccine Production Sites and Area Served
        6.4.2 Novartis Description, Business Overview and Total Revenue
        6.4.3 Novartis Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Novartis Products Offered
        6.4.5 Novartis Recent Development
    6.5 Pfizer
        6.5.1 Pfizer Adult Vaccine Production Sites and Area Served
        6.5.2 Pfizer Description, Business Overview and Total Revenue
        6.5.3 Pfizer Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Pfizer Products Offered
        6.5.5 Pfizer Recent Development
    6.6 BioCSL (Seqirus)
        6.6.1 BioCSL (Seqirus) Adult Vaccine Production Sites and Area Served
        6.6.2 BioCSL (Seqirus) Description, Business Overview and Total Revenue
        6.6.3 BioCSL (Seqirus) Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 BioCSL (Seqirus) Products Offered
        6.6.5 BioCSL (Seqirus) Recent Development
    6.7 Protein Sciences
        6.6.1 Protein Sciences Adult Vaccine Production Sites and Area Served
        6.6.2 Protein Sciences Description, Business Overview and Total Revenue
        6.6.3 Protein Sciences Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Protein Sciences Products Offered
        6.7.5 Protein Sciences Recent Development

7 Adult Vaccine Manufacturing Cost Analysis
    7.1 Adult Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Adult Vaccine
    7.4 Adult Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Adult Vaccine Distributors List
    8.3 Adult Vaccine Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Adult Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Adult Vaccine by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Adult Vaccine by Type (2021-2026)
    10.2 Adult Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Adult Vaccine by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Adult Vaccine by Application (2021-2026)
    10.3 Adult Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Adult Vaccine by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Adult Vaccine by Region (2021-2026)
    10.4 North America Adult Vaccine Estimates and Projections (2021-2026)
    10.5 Europe Adult Vaccine Estimates and Projections (2021-2026)
    10.6 Asia Pacific Adult Vaccine Estimates and Projections (2021-2026)
    10.7 Latin America Adult Vaccine Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Adult Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Adult Vaccine Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Adult Vaccine Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Adult Vaccine Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Adult Vaccine Manufacturers Covered in This Study Table 5. Global Adult Vaccine Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Adult Vaccine Sales Share by Manufacturers (2015-2020) Table 7. Global Adult Vaccine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Adult Vaccine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Adult Vaccine Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Adult Vaccine Sales Sites and Area Served Table 11. Manufacturers Adult Vaccine Product Types Table 12. Global Adult Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Adult Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult Vaccine as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Adult Vaccine Players Table 16. Global Adult Vaccine Sales (K MT) by Region (2015-2020) Table 17. Global Adult Vaccine Sales Market Share by Region (2015-2020) Table 18. Global Adult Vaccine Revenue (Million US$) by Region (2015-2020) Table 19. Global Adult Vaccine Revenue Market Share by Region (2015-2020) Table 20. North America Adult Vaccine Sales by Country (2015-2020) (K MT) Table 21. North America Adult Vaccine Sales Market Share by Country (2015-2020) Table 22. North America Adult Vaccine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Adult Vaccine Revenue Market Share by Country (2015-2020) Table 24. Europe Adult Vaccine Sales by Country (2015-2020) (K MT) Table 25. Europe Adult Vaccine Sales Market Share by Country (2015-2020) Table 26. Europe Adult Vaccine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Adult Vaccine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Adult Vaccine Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Adult Vaccine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Adult Vaccine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Adult Vaccine Revenue Market Share by Region (2015-2020) Table 32. Latin America Adult Vaccine Sales by Country (2015-2020) (K MT) Table 33. Latin America Adult Vaccine Sales Market Share by Country (2015-2020) Table 34. Latin America Adult Vaccine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Adult Vaccine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Adult Vaccine Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Adult Vaccine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Adult Vaccine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Adult Vaccine Revenue Market Share by Country (2015-2020) Table 40. Global Adult Vaccine Sales (K MT) by Type (2015-2020) Table 41. Global Adult Vaccine Sales Share by Type (2015-2020) Table 42. Global Adult Vaccine Revenue (Million US$) by Type (2015-2020) Table 43. Global Adult Vaccine Revenue Share by Type (2015-2020) Table 44. Global Adult Vaccine Price (USD/MT) by Type (2015-2020) Table 45. Global Adult Vaccine Sales (K MT) by Application (2015-2020) Table 46. Global Adult Vaccine Sales Market Share by Application (2015-2020) Table 47. Global Adult Vaccine Sales Growth Rate by Application (2015-2020) Table 48. GlaxoSmithKline Adult Vaccine Corporation Information Table 49. GlaxoSmithKline Description and Business Overview Table 50. GlaxoSmithKline Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. GlaxoSmithKline Main Product Table 52. GlaxoSmithKline Recent Development Table 53. Sanofi Pasteur Adult Vaccine Corporation Information Table 54. Sanofi Pasteur Corporation Information Table 55. Sanofi Pasteur Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Sanofi Pasteur Main Product Table 57. Sanofi Pasteur Recent Development Table 58. Merck Adult Vaccine Corporation Information Table 59. Merck Corporation Information Table 60. Merck Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Merck Main Product Table 62. Merck Recent Development Table 63. Novartis Adult Vaccine Corporation Information Table 64. Novartis Corporation Information Table 65. Novartis Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Novartis Main Product Table 67. Novartis Recent Development Table 68. Pfizer Adult Vaccine Corporation Information Table 69. Pfizer Corporation Information Table 70. Pfizer Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Pfizer Main Product Table 72. Pfizer Recent Development Table 73. BioCSL (Seqirus) Adult Vaccine Corporation Information Table 74. BioCSL (Seqirus) Corporation Information Table 75. BioCSL (Seqirus) Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. BioCSL (Seqirus) Main Product Table 77. BioCSL (Seqirus) Recent Development Table 78. Protein Sciences Adult Vaccine Corporation Information Table 79. Protein Sciences Corporation Information Table 80. Protein Sciences Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Protein Sciences Main Product Table 82. Protein Sciences Recent Development Table 83. Sales Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Adult Vaccine Distributors List Table 86. Adult Vaccine Customers List Table 87. Market Key Trends Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 89. Key Challenges Table 90. Global Adult Vaccine Sales (K MT) Forecast by Type (2021-2026) Table 91. Global Adult Vaccine Sales Market Share Forecast by Type (2021-2026) Table 92. Global Adult Vaccine Revenue (Million US$) Forecast by Type (2021-2026) Table 93. Global Adult Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 94. Global Adult Vaccine Sales (K MT) Forecast by Application (2021-2026) Table 95. Global Adult Vaccine Revenue (Million US$) Forecast by Application (2021-2026) Table 96. Global Adult Vaccine Sales (K MT) Forecast by Region (2021-2026) Table 97. Global Adult Vaccine Sales Market Share Forecast by Region (2021-2026) Table 98. Global Adult Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 99. Global Adult Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Adult Vaccine Figure 2. Global Adult Vaccine Sales Market Share by Type: 2020 VS 2026 Figure 3. Influenza Product Picture Figure 4. Cervical Cancer Product Picture Figure 5. Zoster Shingles Product Picture Figure 6. Pneumococcal Product Picture Figure 7. Meningococcal Product Picture Figure 8. MMRV Product Picture Figure 9. Hepatitis Product Picture Figure 10. DTP Product Picture Figure 11. Travel and Miscellaneous Product Picture Figure 12. Global Adult Vaccine Consumption Market Share by Application: 2020 VS 2026 Figure 13. Hospitals Figure 14. Medical Care Centers Figure 15. Other Figure 16. Global Adult Vaccine Market Size 2015-2026 (US$ Million) Figure 17. Global Adult Vaccine Sales Capacity (K MT) (2015-2026) Figure 18. Global Adult Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 19. Adult Vaccine Sales Share by Manufacturers in 2020 Figure 20. Global Adult Vaccine Revenue Share by Manufacturers in 2019 Figure 21. The Global 5 and 10 Largest Players: Market Share by Adult Vaccine Revenue in 2019 Figure 22. Adult Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Adult Vaccine Sales Market Share by Region (2015-2020) Figure 24. Global Adult Vaccine Sales Market Share by Region in 2019 Figure 25. Global Adult Vaccine Revenue Market Share by Region (2015-2020) Figure 26. Global Adult Vaccine Revenue Market Share by Region in 2019 Figure 27. North America Adult Vaccine Sales Market Share by Country in 2019 Figure 28. North America Adult Vaccine Revenue Market Share by Country in 2019 Figure 29. U.S. Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 30. U.S. Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. Canada Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 32. Canada Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Europe Adult Vaccine Sales Market Share by Country in 2019 Figure 34. Europe Adult Vaccine Revenue Market Share by Country in 2019 Figure 35. Germany Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 36. Germany Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. France Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 38. France Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. U.K. Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 40. U.K. Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Italy Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 42. Italy Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Russia Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 44. Russia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Asia Pacific Adult Vaccine Sales Market Share by Region in 2019 Figure 46. Asia Pacific Adult Vaccine Revenue Market Share by Region in 2019 Figure 47. China Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 48. China Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Japan Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 50. Japan Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. South Korea Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 52. South Korea Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. India Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 54. India Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Australia Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 56. Australia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Taiwan Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 58. Taiwan Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Indonesia Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 60. Indonesia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Thailand Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 62. Thailand Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Malaysia Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 64. Malaysia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Philippines Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 66. Philippines Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Vietnam Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 68. Vietnam Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Latin America Adult Vaccine Sales Market Share by Country in 2019 Figure 70. Latin America Adult Vaccine Revenue Market Share by Country in 2019 Figure 71. Mexico Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 72. Mexico Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Brazil Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 74. Brazil Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Argentina Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 76. Argentina Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Middle East and Africa Adult Vaccine Sales Market Share by Country in 2019 Figure 78. Middle East and Africa Adult Vaccine Revenue Market Share by Country in 2019 Figure 79. Turkey Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 80. Turkey Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Saudi Arabia Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 82. Saudi Arabia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. U.A.E Adult Vaccine Sales Growth Rate (2015-2020) (K MT) Figure 84. U.A.E Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Sales Market Share of Adult Vaccine by Type (2015-2020) Figure 86. Sales Market Share of Adult Vaccine by Type in 2019 Figure 87. Revenue Share of Adult Vaccine by Type (2015-2020) Figure 88. Revenue Market Share of Adult Vaccine by Type in 2019 Figure 89. Global Adult Vaccine Sales Growth by Type (2015-2020) (K MT) Figure 90. Global Adult Vaccine Sales Market Share by Application (2015-2020) Figure 91. Global Adult Vaccine Sales Market Share by Application in 2019 Figure 92. Global Revenue Share of Adult Vaccine by Application (2015-2020) Figure 93. Global Revenue Share of Adult Vaccine by Application in 2020 Figure 94. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. BioCSL (Seqirus) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Protein Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Price Trend of Key Raw Materials Figure 102. Manufacturing Cost Structure of Adult Vaccine Figure 103. Manufacturing Process Analysis of Adult Vaccine Figure 104. Adult Vaccine Industrial Chain Analysis Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Porter's Five Forces Analysis Figure 108. North America Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 109. North America Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Europe Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 111. Europe Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. Latin America Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. Middle East and Africa Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 117. Asia Pacific Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Bottom-up and Top-down Approaches for This Report Figure 119. Data Triangulation Figure 120. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Other Reports by QY Research

Global Phenylalanine Market Research Report 2020

Market Analysis and Insights: Global Phenylalanine Market The global Phenylalanine market is valued at US$ 642.5 million in 2019 and is expected to reach US$ 743.25 million by the end of 2026, growing at a CAGR of 2.29% during 2020-2026. Global Pheny...

Global Medical Electrical Bathtub Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

Market Analysis and Insights: Global Medical Electrical Bathtub Market In 2019, the global Medical Electrical Bathtub market size was US$ 104 million and it is expected to reach US$ 162 million by the end of 2026, with a CAGR of 6.6% between 2020 and...

Global Injection Molding Machinery Sales Market Report 2019

The global Injection Molding Machinery market was valued at 10884.04 million US$ in 2019 and will reach 13305.52 million US$ by the end of 2025, growing at a CAGR of 3.4% during 2019-2025. This report studies the global Injection Molding Machinery m...

Global Fitness Equipment Sales Market Report 2020

Market Analysis and Insights: Global Fitness Equipment Market The global Fitness Equipment market was valued at US$ 8013.0 million in 2019 and will reach US$ 10327.9 million by the end of 2026, growing at a CAGR of 3.66% during 2020-2026. Global Fitn...

Global Cement and Aggregate Market Insights, Forecast to 2026

Market Analysis and Insights: Global Cement and Aggregate Market The global Cement and Aggregate market is valued at US$ 190345 million in 2019. The market share will reach US$ 225817 million by the end of 2026, growing at a CAGR of 2.59% during 2020...

Publisher: QY Research